Ampersand Capital Partners, a private equity firm with a deep focus on life sciences and healthcare growth investments, has announced the opening of a new office in London. This move marks a significant milestone in the firm’s ongoing expansion across Europe. This new location builds on the success of Ampersand’s Amsterdam office, which was launched in 2017 and has since played a pivotal role in the firm’s European strategy.
The decision to establish a London presence reflects Ampersand’s long-term commitment to supporting innovative healthcare companies across the continent. With its roots in Boston and a growing footprint in Amsterdam, the firm has steadily evolved into a global force in healthcare private equity. The London office now adds another strategic hub, positioning Ampersand to serve its portfolio companies better and identify new opportunities in one of the world’s most dynamic financial centers.
As part of this expansion, Ampersand has welcomed Matthew Norton as a General Partner based in London. Norton brings more than 15 years of experience in healthcare-focused private equity, most recently serving as a Partner at Cinven. During his tenure there, he played a key role in shaping the firm’s healthcare strategy and led transformative growth initiatives across both Europe and the United States. His appointment signals Ampersand’s intent to deepen its engagement with European markets and accelerate its investment activity in the region.
Joining Norton in London is Marina Pellon-Consunji, who will be relocating from Amsterdam. Marina has been instrumental in building Ampersand’s European presence over the past several years, leading multiple platform investments and executing a series of strategic add-on acquisitions. Her move to London is a natural progression, allowing her to continue driving Ampersand’s European growth efforts while working alongside Norton to expand the firm’s reach and impact.
For over three decades, Ampersand has focused on building market-leading businesses in the life sciences and healthcare sectors. Its portfolio spans a wide range of specialties, including lab products, lab services, contract manufacturing, pharma services, and specialty healthcare products. The firm’s approach is hands-on and growth-oriented, working closely with management teams to accelerate performance and unlock long-term value.
The opening of the London office is more than just a geographic expansion. With established offices in Boston and Amsterdam, and now a strong presence in London, the firm is poised to support innovation and growth across multiple continents. As the healthcare landscape continues to shift and expand, Ampersand’s commitment to building exceptional companies remains as strong as ever.
KEY QUOTE:
“We are pleased to announce the addition of Matthew Norton to Ampersand’s team, along with the opening of a London office. With Matt’s and Marina’s experience and leadership, we are well-positioned to continue identifying and scaling the next generation of global healthcare and life sciences companies.”
Herb Hooper, Managing Partner of Ampersand
